Executive Compensation

Exhibit 10.1

 

Executive Compensation

 

                At a meeting of the Compensation Committee of the Board of Directors of Allos Therapeutics, Inc. (the “Company”) held on February 25, 2008, the Compensation Committee determined and approved 2007 cash bonus awards and 2008 base salaries and target bonus awards (expressed as a percentage of base salary) for the Company’s “named executive officers” (as defined in Item 402(a)(3) of Regulation S-K promulgated by the Securities and Exchange Commission) as set forth in the table below.  The 2008 target bonus award (expressed as a percentage of base salary) for the Chief Executive Officer was also reviewed and approved by the full Board of Directors at a meeting held on February 25, 2008.

 

Name and Title

 

2007
Bonus
Award

 

2008
Base
Salary

 

2008
Target
Bonus (%)

 

Paul L. Berns
President and Chief Executive Officer

 

$

280,752

 

$

500,850

 

60%

 

Pablo J. Cagnoni, M.D.
Senior Vice President, Chief Medical Officer

 

$

124,997

 

$

404,250

 

40%

 

James V. Caruso
Executive Vice President, Chief Commercial Officer

 

$

154,857

 

$

398,580

 

40%

 

Marc H. Graboyes
Senior Vice President, General Counsel and Secretary

 

$

73,210

 

$

300,583

 

30%

 

David C. Clark
Vice President, Finance and Treasurer

 

$

53,166

 

$

210,000

 

25%